QPRT: A potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Hinsch, Nora ^a   Frank, Matthias ^a   Döring, Claudia ^a,b   Vorländer, Christian ^c   Hansmann, Martin Leo ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Burgerhospital Frankfurt am Main   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINATE NUCLEOTIDE PYROPHOSPHORYLASE (CARBOXYLATING); PHOSPHORIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; GLYCOSYLTRANSFERASE; NICOTINATE NUCLEOTIDE DIPHOSPHORYLASE (CARBOXYLATING); NICOTINATE-NUCLEOTIDE DIPHOSPHORYLASE (CARBOXYLATING); RNA; TUMOR MARKER;

ARTICLE; CANCER INVASION; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MARKER GENE; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; ADENOCARCINOMA; ADENOMA; CLUSTER ANALYSIS; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID TUMOR; WESTERN BLOTTING;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; BLOTTING, WESTERN; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PENTOSYLTRANSFERASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 65349094683     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-93     Document Type: Article

References (33)

1. Stewart BW Kleihues P Thyroid cancer World cancer report Lyon: IARC Press Stewart BW, Kleihues P 2003, 257-260.
2. Hoelzer S Steiner D Bauer R Reiners C Farahati J Hundahl SA Dudeck J Current practice of radioiodine treatment in the management of differentiated thyroid cancer in germany Eur J Nucl Med 2000, 27:1465-1472. 10.1007/s002590000333 11083534
3. Schmid KW Farid NR How to define follicular thyroid carcinoma? Virchows Arch 2006, 448:385-393. 10.1007/s00428-006-0162-0 16506015
4. DeLellis RA Lloyd R Heitz PU Eng C (Eds) WHO histological classification of thyroid and parathyroid tumour World Health Organization classification of tumours. Pathology and genetics. Tumours of endocrine organs Lyon: IARC Press 2004, 49:123.
5. Franc B de la Salmoniere P Lange F Hoang C Louvel A de Roquancourt A Vildé F Hejblum G Chevret S Chastang C Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma Hum Pathol 2003, 34:1092-1100. 10.1016/ S0046-8177(03)00403-9 14652809
6. Hirokawa M Carney JA Goellner JR DeLellis RA Heffess CS Katoh R Tsujimoto M Kakudo K Observer variation of encapsulated follicular lesions of the thyroid gland Am J Surg Pathol 2002, 26:1508-1514. 10.1097/00000478-200211000-00014 12409728
7. Chung KW Yang SK Lee GK Kim EY Kwon S Lee SH Park do J Lee HS Cho BY Lee ES Kim SW Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent areas Clin Endocrinol (Oxf) 2006, 65:660-666. 10.1111/j.1365-2265.2006.02646.x 17054470
8. Hibi Y Nagaya T Kambe F Imai T Funahashi H Nakao A Seo H Is thyroid follicular cancer in Japanese caused by a specific t(2;3)(q13;p25) translocation generating Pax8-PPAR fusion mRNA? Endocr J 2004, 51:361-366. 10.1507/endocrj.51.361 15256783
9. Lacroix L Mian C Barrier T Talbot M Caillou B Schlumberger M Bidart JM PAY8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues Eur J Endocrinol 2004, 151:367-374. 10.1530/eje.0.1510367 15362967
10. Marques AR Espadinha C Catarino AL Moniz S Pereira T Sobrinho LG Leite V Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas J Clin Endocrin Metab 2002, 87:3947-3952. 10.1210/jc.87.8.3947
11. Nikiforova MN Lynch RA Biddinger PW Biddinger PW Alexander EK Dorn GW 2nd Tallini G Kroll TG Nikiforov YE Ras point mutations and PAX8-PPAR gamma rearrangements in thyroid tumours: Evidence for distinct molecular pathways in thyroid follicular carcinoma J Clin Endocrin Metab 2003, 88:2318-2326. 10.1210/jc.2002-021907
12. R Development Core Team R: A language and environment for statistical computing. [computer program] R Foundation for Statistical Computing, Vienna, Austria 2005.
13. Gentleman RC Carey VJ Bates DM Bolstad B Dettling M Dudoit S Ellis B Gautier L Ge Y Gentry J Hornik K Hothorn T Huber W Iacus S Irizarry R Leisch F Li C Maechler M Rossini AJ Sawitzki G Smith C Smyth G Tierney L Yang JY Zhang J Bioconductor: Open software development for computational biology and bioinformatics Genome Biology 2004, 5:R80. 545600 15461798 10.1186/gb-2004-5-10-r80
14. Tukey JW Exploratory Data Analysis Reading Massachusetts: Addison-Wesley 1977.
15. Benjamini Y Hochberg Y Controlling the false discovery rate: A practical and powerful approach to multiple testing J R Statist Soc B 1995, 57:289-300.
16. Bolstad B Irizarry R Strand M Speed T A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/ 19.2.185 12538238
17. Moore D Bice T Jin L Grandhi A DeLucas LJ Narayana SV Crystallization and preliminary crystallographic investigation of porcine quinolinate phosphoribosyltransferase Acta Crystallogr D Biol Crytallogr 1998, 54:119-120. 10.1107/S090744499700807X
18. Stone TW Perkins MN Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS Eur J Pharmacol 1981, 72:411-412. 10.1016/ 0014-2999(81)90587-2 6268428
19. Fukuoka S Ishiguro K Yanagihara K Tanabe A Egashira Y Sanada H Shibata K Identification and expression of a cDNA encoding human alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD). A key enzyme for the tryptophan-niacin pathway and "quinolinate hypothesis" J Biol Chem 2002, 277:35162-35167. 10.1074/jbc.M200819200 12140278
20. Foster AC Whetsell WO Bird ED Schwarcz R Quinolinic acid phosphoribosyltransferase in human and rat brain: Activity in Huntigton's disease and in quinolinate-lesioned rat striatum Brain Res 1985, 336:207-214. 10.1016/0006-8993(85)90647-X 3159462
21. Köhler C Eriksson LG Flood PR Hardie JA Okuno E Schwarcz R Quinolinic acid phosphoribosyltransferase: Preferential glial localization in the rat brain visualized by immunocytochemistry Proc Natl Acad Sci 1987, 84:3491-3495. 304897 3472219 10.1073/pnas.84.10.3491
22. Okuno E White RJ Schwarcz R Quinolinic acid phosphoribosyltransferase: purification and partial characterization from human liver and brain J Biochem 1988, 103:1054-1059. 3139649
23. Foster AC Schwarcz R Characterization of quinolinic acid phosphorybosyltransferase in human blood and observations in Huntington's disease J Neurochem 1985, 45:199-205. 10.1111/ j.1471-4159.1985.tb05493.x 2582090
24. Arslan AA Gold LI Mittal K Suen TC Belitskaya-Levy I Tang MS Toniolo P Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: New evidence and a systematic review Hum Rep 2005, 20:852-863. 10.1093/humrep/deh698
25. Barden CB Shister KW Zhu B Guiter G Greenblatt DY Zeiger MA Fahey TJ 3rd Classification of follicular thyroid tumors by molecular signature: results of gene profiling Clin Cancer Res 2003, 9:1792-1800. 12738736
26. Cerutti JM Delcelo R Amadei MJ Nakabashi C Maciel RM Peterson B Shoemaker J Riggins GJ A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression J Clin Invest 2004, 113:1234-1242. 385398 15085203
27. Fryknas M Wickenberg-Bolin U Göransson H Gustafsson MG Foukakis T Lee JJ Landegren U Höög A Larsson C Grimelius L Wallin G Pettersson U Isaksson A Molecular markers for discrimination of benign and malignant follicular thyroid tumors Tumor Biol 2006, 27:211-220. 10.1159/000093056
28. Puskas LG Juhasz F Zarva A Hackler L Jr Farid NR Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors Cell Mol Biol 2005, 51:177-186. 16171553
29. Stolf BS Santos MM Simao DF Diaz JP Cristo EB Hirata R Jr Curado MP Neves EJ Kowalski LP Carvalho AF Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression Cancer 2006, 106:1891-1900. 10.1002/ cncr.21826 16565969
30. Weber F Shen L Aldred MA Morrison CD Frilling A Saji M Schuppert F Broelsch CE Ringel MD Eng C Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination J Clin Endocrin Metab 2005, 90:2512-2521. 10.1210/jc.2004-2028
31. Cerutti JM Latini FR Nakabashi C Delcelo R Andrade VP Amadei MJ Maciel RM Hojaij FC Hollis D Shoemaker J Riggins GJ Diagnosis of suspicious thyroid nodules using four protein biomarkers Clin Cancer Res 2006, 12:3311-3318. 10.1158/1078-0432.CCR-05-2226 16740752
32. de Matos PS Ferreira AP de Oliveira Facuri F Assumpção LV Metze K Ward LS Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy Histopathology 2005, 47:391-401. 10.1111/j.1365-2559.2005.02221.x 16178894
33. Park YJ Kwak SH Kim DC Kim H Choe G Park do J Jang HC Park SH Cho BY Park SY Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27kip1 in the differential diagnosis of thyroid nodules J Korean Med Sci 2007, 22:621-6. 17728499